Differential effect of benexate hydrochloride betadex on prostaglandin levels in stomach and inflammatory site in rats
Differential effect of benexate hydrochloride betadex on prostaglandin levels in stomach and inflammatory site in rats
复制标题
DOI:
10.1254/jjp.72.183
复制
发表时间:
1996-10-01
期刊:
影响因子:
--
通讯作者:
Mizui, T
中科院分区:
文献类型:
--
作者:
Hori, Y;Odaguchi, K;Mizui, T
We compared the effects of an anti-ulcer agent, benexate hydrochloride betadex (BHB), on prostaglandin (PG) levels in gastric tissue and inflammatory exudate in untreated and indomethacin-treated rats. BHB (100, 300 and 1000 mg/kg, p.o.) showed dose-dependent inhibition of gastric mucosal lesions induced by indomethacin (30 mg/kg, p.o.). Sustained decrease of PGs (PGE(2) and 6-keto-PGF(1 alpha)) in the gastric wall was observed from 0.5 to 6 hr after indomethacin treatment. BHB (300 and 1000 mg/kg) dose-dependently led to recovery of the indomethacin-induced decrease of gastric PGs at 1 and 6 hr after dosing. It did not antagonize the indomethacin-induced decrease of PG levels in the pleural exudate of carrageenin pleurisy nor did it affect the anti-inflammatory effects of indomethacin. BHB (100 to 1000 mg/kg) alone increased gastric PGE(2) by 61% to 113%, while it decreased PGE(2) levels in the pleural exudate by 9% to 71% at 6 hr after dosing. These results suggest that sustained increase of gastric PGE(2) by BHB could be responsible for protection against indomethacin-induced gastric mucosal lesions and that BHB is a suitable anti-ulcer agent for NSAIDs without compromising their anti-inflammatory effects.